BDKRB2 anticorps (N-Term)
Aperçu rapide pour BDKRB2 anticorps (N-Term) (ABIN630235)
Antigène
Voir toutes BDKRB2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- Bradykinin Receptor B2 antibody was raised against the N terminal of BDKRB2
-
Purification
- Purified
-
Immunogène
- Bradykinin Receptor B2 antibody was raised using the N terminal of BDKRB2 corresponding to a region with amino acids MFSPWKISMFLSVREDSVPTTASFSADMLNVTLQGPTLNGTFAQSKCPQV
-
-
-
-
Indications d'application
-
WB: 5 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
Bradykinin Receptor B2 Blocking Peptide, (ABIN5612357), is also available for use as a blocking control in assays to test for specificity of this Bradykinin Receptor B2 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of BDKRB2 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- BDKRB2 (Bradykinin Receptor B2 (BDKRB2))
-
Autre désignation
- Bradykinin Receptor B2
-
Sujet
- BDKRB2 is a receptor for bradykinin. The 9 aa bradykinin peptide elicits many responses including vasodilation, edema, smooth muscle spasm and pain fiber stimulation. This receptor associates with G proteins that stimulate a phosphatidylinositol-calcium second messenger system.
-
Poids moléculaire
- 43 kDa (MW of target protein)
-
Pathways
- ACE Inhibitor Pathway, Negative Regulation of intrinsic apoptotic Signaling
Antigène
-